LATEST ARTICLES Results from the CodeBreak 200, EMPOWER-Lung 1, IPSOS, and ADAURA trials highlight the efficacy of immunotherapy and targeted therapies in non-small cell lung cancer.
Results from the TROPiCS-02, DATA, GIM2, and METEORA-II trials may help inform the treatment of breast cancer.
New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.
Cancer patients who have survived sexual trauma can present with complex sensitivities that require a trauma-informed approach to care.
Changes to abortion laws in the US could have unintended consequences for cancer patients and others seeking fertility preservation.
Acupuncture and moxibustion, which are sometimes used together, have shown promise for reducing insomnia in patients with cancer.
Sublobar resection is noninferior to a full lobectomy in patients with carefully staged cT1aN0 non-small cell lung cancer, new research suggests.
Experts discuss current and potential future shortages affecting the oncology field as well as strategies for preventing and managing shortages.
Implicit bias among health care providers factors into judgments and influences clinical decision making.
An expert outlines ways to improve outcomes for older patients with ovarian cancer.
Conference organizers are taking steps to protect attendees from COVID-19, but some oncology professionals think more needs to be done.
The Pathways Heart Study provides new insight into how breast cancer treatments affect the risk of cardiovascular disease.
Studies have indicated that smoking marijuana may not increase a person’s risk of lung cancer, but robust evidence is lacking.
Survey results suggest that many oncologists experience sexual harassment in the workplace.
Though cancer cachexia has been researched extensively, it remains challenging to understand and treat.
Load More
